1 Min Read
Nov 1 (Reuters) -
* Valeant is in talks to sell its Salix stomach-drug business for about $10 billion - WSJ Source text - on.wsj.com/2eaPVeQ Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.